Cargando…
Selection and expansion of natural killer cells for NK cell-based immunotherapy
Natural killer (NK) cells have been used in several clinical trials as adaptive immunotherapy. The low numbers of these cells in peripheral blood mononuclear cells (PBMC) have resulted in various approaches to preferentially expand primary NK cells from PBMC. While some clinical trials have used the...
Autores principales: | Becker, Petra S. A., Suck, Garnet, Nowakowska, Paulina, Ullrich, Evelyn, Seifried, Erhard, Bader, Peter, Tonn, Torsten, Seidl, Christian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4826432/ https://www.ncbi.nlm.nih.gov/pubmed/26810567 http://dx.doi.org/10.1007/s00262-016-1792-y |
Ejemplares similares
-
2011: the immune hallmarks of cancer
por: Cavallo, Federica, et al.
Publicado: (2011) -
Potential therapeutic approach for the hormonal treatment of lacrimal gland dysfunction in Sjögren's syndrome
por: Sullivan, David A., et al.
Publicado: (1992) -
Deciphering myeloid-derived suppressor cells: isolation and markers in humans, mice and non-human primates
por: Cassetta, Luca, et al.
Publicado: (2019) -
Role of myeloid regulatory cells (MRCs) in maintaining tissue homeostasis and promoting tolerance in autoimmunity, inflammatory disease and transplantation
por: Amodio, Giada, et al.
Publicado: (2018) -
Activation-induced cytidine deaminase (AID) linking immunity, chronic inflammation, and cancer
por: Mechtcheriakova, Diana, et al.
Publicado: (2012)